Twelfth Magpie Premium
  1. Tag
    2. /
  2. Dechra Pharmaceuticals
    3. /

Dechra Pharmaceuticals

Top Articles

Happy senior couple hugging and enjoying retirement at home
Investing Articles

Up 105% In 3 Months! Here’s Our Top Growth Stock For July 2026 [PREMIUM PICKS]

| Mark Rogers

One AI tailwind just sent this stock up 105% in 3 months... and we think our top growth stock is…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Just Released: Our Top Value Stock For ISAs In June 2026 [PREMIUM PICKS]

| Mark Rogers

We've just named our top value stock for June 2026 with 31 years of dividend growth under its belt, still…

Read more »

Investing Articles

An Important Update From The Motley Fool UK

| Mark Rogers

The future of The Motley Fool UK is here.

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Just Released: Our Top Defence Stock For ISAs In May 2026 [PREMIUM PICKS]

| Mark Rogers

Fire stock picks will tend to be more adventurous and are designed for investors who can stomach a bit more…

Read more »

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

Just Released: Our Top Growth-Focused Stock For ISAs In April 2026 [PREMIUM PICKS]

| Mark Rogers

Fire stock picks will tend to be more adventurous and are designed for investors who can stomach a bit more…

Read more »

Senior couple are walking their dog through a public park in Autumn.
Investing Articles

Just Released: A Lower-Risk, Passive Income Stock Recomendation For Your ISA? [PREMIUM PICKS]

| Mark Rogers

Passive income Ice stock picks will tend to be more conservative and are designed for investors looking to protect their…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£500 buys 259 shares in this 6.5% yielding income stock! [PREMIUM PICKS]

| Mark Rogers

Here are the 3 latest income stock picks from the Share Advisor UK team, with high yields and other bullish…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Just Released: A Higher-Risk, High-Reward Stock Recommendation For Your ISA? [PREMIUM PICKS]

| Mark Rogers

Fire stock picks will tend to be more adventurous and are designed for investors who can stomach a bit more…

Read more »

Recent Dechra Pharmaceuticals News

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

I’d buy the dip in share prices as there are bargains to be had right now

| Harvey Jones

There are great opportunities when share prices are falling and I'm looking for the best way to buy the dip…

Read more »

Investing Articles

FTSE 100 reshuffle: time to buy this hot growth stock?

| Paul Summers

This growth stock's promotion to the FTSE 100 (INDEXFTSE:UKX) looks nailed on. So, are the shares still a buy? Paul…

Read more »

Investing Articles

No savings at 40? I’d buy these 2 fast-growing FTSE 100 stocks to top up the State Pension

| Harvey Jones

These two stocks offer growth today and protection in case of a market correction, in my opinion.

Read more »

Investing Articles

I tipped these 2 FTSE 250 stocks to outperform in 2019. Next year looks promising too

| Harvey Jones

Harvey Jones says these FTSE 250 (INDEXFTSE:UKX) have shown their worth in 2019.

Read more »

Investing Articles

£6k to invest? These three growth champions are my top buys for 2020!

| Rupert Hargreaves

These growth champions dominate their respective markets and should continue to beat them for many years to come, argues Rupert…

Read more »

Investing Articles

Expensive but exceptional! 3 FTSE 250 growth shares that could help you to retire early

| Royston Wild

These FTSE 100 (INDEXFTSE: UKX) stocks may be expensive but they're worth every penny, argues Royston Wild.

Read more »

Investing Articles

Want to get rich? 3 FTSE 250 growth stocks that I’d buy and hold for the next 10 years

| Royston Wild

These growth giants from the FTSE 250 (INDEXFTSE: MCX) look set to thrive through the next 10 years at least,…

Read more »

Investing Articles

I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

| Harvey Jones

Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year.

Read more »

Investing Articles

2 FTSE 250 dividend stocks I’d buy and hold for 25 years

| Royston Wild

Royston Wild zeroes in on two terrific FTSE 250 (INDEXFTSE: MCX) income heroes that could make you richer.

Read more »

Investing Articles

GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now

| Kevin Godbold

Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm.

Read more »

Investing Articles

3 of the best growth stocks of 2018 (so far)

| Royston Wild

Royston Wild runs the rule over three stocks whose share prices have detonated in 2018. Can they keep climbing?

Read more »

Investing Articles

One super growth stock I’d buy ahead of SXX shares

| Edward Sheldon, CFA

Edward Sheldon explains why he won't be buying shares of Sirius Minerals plc (LON: SXX).

Read more »

Investing Articles

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

| Royston Wild

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune.

Read more »

Investing Articles

Does Halma plc’s double-digit growth make it the steal of the century?

| Alan Oscroft

Halma plc (LON: HLMA) has seen its earnings soar, and here's another that's done even better.

Read more »

Investing Articles

Looking to invest £2,000? Here are 2 pharma stocks I’d buy today

| Harvey Jones

Harvey Jones says these two pharmaceutical stocks have something to please both momentum and contrarian investors.

Read more »

Investing Articles

2 no-brainer stocks I’d buy in pharma

| Royston Wild

Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth.

Read more »

Investing Articles

2 opportunities to beat the FTSE 100 which won’t last forever

| Peter Stephens

These two stocks could help you to generate higher returns than the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

2 pharma stocks that could make you a millionaire

| Royston Wild

The FTSE 100 isn’t the last word for great pharmaceutical stocks. Here, Royston Wild looks at two medical marvels outside…

Read more »

Investing Articles

A growth-plus-dividend stock I’d buy ahead of Vodafone Group plc

| Alan Oscroft

Vodafone Group plc (LON:VOD) offers big dividends, but here's a smaller stock that could be a better buy.

Read more »

Investing Articles

2 stocks that could make you rich

| Bilaal Mohamed

Bilaal Mohamed identifies two London-listed firms with spectacular growth potential.

Read more »

Investing Articles

This FTSE 250 dog might be a stonking contrarian pick

| Paul Summers

Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock.

Read more »

Investing Articles

2 surprising growth stocks that could help you retire early

| Peter Stephens

These two shares may offer higher growth rates than expected.

Read more »

Investing Articles

These great growth stocks have much further to go

| Royston Wild

Royston Wild looks at two stocks with hot earnings prospects.

Read more »

Investing Articles

One growth stock I’d buy — and one I’d sell — right now

| Royston Wild

Royston Wild discusses two growth stocks with very different near-term outlooks.

Read more »

Investing Articles

Enjoy double-digit earnings growth with these FTSE 250 stars

| Royston Wild

Royston Wild looks at three FTSE 250 (INDEXFTSE: MCX) stocks with spectacular earnings potential.

Read more »

Investing Articles

Why I’m avoiding these exciting growth shares right now

| Bilaal Mohamed

Bilaal Mohamed explains why investors should wait before buying these growth stocks.

Read more »

Investing Articles

Should you make room for Pets At Home Group plc after today’s update?

| Paul Summers

The market may not like today's update but Paul Summers thinks Pets At Home Group plc (LON:PETS) is a sound…

Read more »

Investing Articles

Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

| Peter Stephens

Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock?

Read more »

Investing Articles

4 growth stocks to put on your 2017 shopping list

| Royston Wild

Royston Wild runs the rule over some of London’s hottest growth stocks.

Read more »

Investing Articles

Could these top-performing stocks be about to collapse?

| Bilaal Mohamed

Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains.

Read more »

Investing Articles

2 shining pharmaceuticals stars to challenge the big guns?

| Alan Oscroft

Can these smaller upstarts beat the champions at their own game?

Read more »

Investing Articles

Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

| Royston Wild

Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

4 perfect stocks for ‘Brexit Britain’!

| Royston Wild

Royston Wild reveals a cluster of stocks waiting to deliver plump shareholder returns.

Read more »

Investing Articles

Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc ‘buys’ after today’s updates?

| Peter Stephens

Should you pile-in to these three stocks right now? RhythmOne plc (LON: RTHM), Dechra Pharmaceuticals plc (LON: DPH) and Pagegroup…

Read more »

Investing Articles

Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today?

| Peter Stephens

Are these three healthcare stocks ripe for investment? AstraZeneca plc (LON: AZN), Alliance Pharma plc (LON: APH) and Dechra Pharmaceuticals…

Read more »

Investing Articles

Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?

| Royston Wild

Royston Wild runs the rule over headline makers Dechra Pharmaceuticals plc (LON: DPH), Enquest Plc (LON: ENQ) and Cairn Energy…

Read more »

Investing Articles

Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On The Cusp Of Stunning Returns?

| Peter Stephens

Could these 3 healthcare stocks transform your portfolio? GlaxoSmithKline plc (LON: GSK), Dechra Pharmaceuticals plc (LON: DPH) and CareTech Holdings…

Read more »

Investing Articles

4 Great Growth Picks For 2016 And Beyond: Barclays PLC, Dechra Pharmaceuticals plc, Britvic Plc And Marks & Spencer Group Plc

| Royston Wild

Royston Wild analyses the growth potential of Barclays PLC (LON: BARC), Dechra Pharmaceuticals plc (LON: DPH), Britvic Plc (LON: BVIC)…

Read more »

Investing Articles

Are AstraZeneca plc, Indivior PLC & Dechra Pharmaceuticals plc Set To Double by 2016?

| Alessandro Pasetti

AstraZeneca plc (LON:AZN), Indivior PLC (LON:INDV) and Dechra Pharmaceuticals plc (LON:DPH) offer three very different risk profiles, argues Alessandro Pasetti.

Read more »

Investing Articles

Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC Are A Perfect Healthcare Combination

| G A Chester

AstraZeneca plc (LON:AZN), Dechra Pharmaceuticals plc (LON:DPH) and Tissue Regenix Group PLC (LON:TRX) are a terrific trio to buy today.

Read more »